Rpg Life Sciences Ltd, based in India, is a pharmaceutical company that stands out with its certifications from EDQM and WHO-GMP.
One of their notable products is AZATHIOPRINE USP, with a corresponding US DMF Number 33056.
Remarkably, this DMF maintains an Active status since its submission on August 09, 2018, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of November 30, 2018, and payment made on August 07, 2018, indicating their dedication to facilitating drug approvals, Categorized as Type II